Clinical trials: sponsored by Tasly Pharmaceutical Group Co., Ltd
Healthy Volunteers
A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.
The purpose of this study is to evaluate the safety，tolerability，and pharmacokinetics of multiple-accending dose of JS1-1-01。
- Trial name
- NCT05656274
- Testing
- JS1-1-01
- Where
- China
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Hyperplasia of Mammary Glands
Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands
This study will evaluate the efficacy and Safety of Xiangjurupining Capsule in the treatment of Hyperplasia of Mammary Glands(stagnation of liver-qi and phlegm).
- Trial name
- NCT06685978
- Testing
- Xiang Ju Ru Pi Ning capsule
- Where
- 27 sites in China
- Volunteers
- 430 people, healthy volunteers welcome
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Healthy
A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects
Jiashen Tablets as an oral, compound traditional chinese medicine prepatations, have an effect on improvement of the heart failure.
- Trial name
- NCT04164290
- Testing
- Jiashen Tablets
- Where
- China
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
Healthy Participants
A Study of Qishenyiqi Dripping Pills in Healthy Participants
This study will evaluate the safety and tolerability of Qishenyiqi Dripping Pills in healthy participants, following oral administration with multiple escalating dose of it.
- Trial name
- NCT04471298
- Testing
- Qishenyiqi dripping pills, 6 bags, Qishenyiqi dripping pills, 9 bags, Qishenyiqi dripping pills, 12 bags
- Where
- China
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd